LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $11,000 | – | 1,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,180,913 | $18,322,000 | 4.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,314,959 | $7,574,000 | 4.38% |
| Perceptive Advisors | 5,910,912 | $34,046,000 | 1.36% |
| P.A.W. CAPITAL CORP | 200,000 | $1,152,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $1,728,000 | 0.78% |
| Broadfin Capital, LLC | 2,105,519 | $12,128,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 683,108 | $3,935,000 | 0.63% |
| Trellus Management Company, LLC | 60,539 | $349,000 | 0.51% |
| Cormorant Asset Management, LP | 499,815 | $2,879,000 | 0.46% |
| QVT Financial LP | 1,433,700 | $8,258,000 | 0.28% |